TORONTO—Swift Medical, a digital wound care provider, announced its new “Skin & Wound 2” platform, which incorporates the latest fast health care interoperability resources standard, as well as imaging and documentation features. The platform has been used for more than 50 million patient assessments in home health, ambulatory, acute and skilled nursing settings.
The Skin & Wound 2 platform aims to offer advancements from the health care landscape and take further advantage of Swift’s artificial intelligence (AI) technologies. The platform’s feature include a user interface that allows for expedited evaluations and submillimeter accuracy.
“Skin & Wound 2 demonstrates our continued commitment to empowering clinicians with the most advanced tools available, enabling the delivery of superior wound care outcomes,” said Dwayne Sansone, CEO of Swift Medical. “For nearly a decade, Swift Medical has been committed to delivering an inclusive, unbiased approach to digital wound care. We see it as our moral responsibility to harness the power of generative AI to revolutionize patient diagnostics, ensuring highly accurate results for every skin tone. Our mission is to heal our world faster by leveraging AI to ensure that every patient, regardless of their background, receives the most precise and equitable care possible.”
“Homecare Homebase has been the leader in integrating the most advanced and reliable patient-focused technologies,” said Scott Pattillo, chief strategy officer of Homecare Homebase. “Our deeply collaborative partnership with Swift provides our customers with the best digital wound care solution in the market to help patients heal faster.”
The company said it is dedicated to increasing scale without compromising quality, which have been motivators for Skin & Wound 2. The platform intends to deploy new features, including additional capabilities planned to release in the next year.
